» Articles » PMID: 10924568

Prediction of Deep Myometrial Invasion in Patients with Endometrial Cancer: Clinical Utility of Contrast-enhanced MR Imaging-a Meta-analysis and Bayesian Analysis

Overview
Journal Radiology
Specialty Radiology
Date 2000 Aug 5
PMID 10924568
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To determine if, in a patient with an endometrial cancer, in addition to the knowledge of tumor grade, preoperative magnetic resonance (MR) imaging findings contribute to treatment stratification and specialist referral.

Materials And Methods: By using a MEDLINE literature search and institutional pathology reports, pretest probabilities for myometrial invasion were correlated with tumor grade. Likelihood ratios (LRs) were obtained through summary receiver operating characteristics.

Results: The mean pretest probabilities of deep myometrial invasion were derived from seven articles (1,875 patients) and from 125 institutional pathology reports. LRs for the prediction of myometrial invasion with contrast-enhanced MR imaging were derived from nine studies (742 patients); positive and negative LRs were 10.11 and 0.1, respectively. The mean weighted pretest probabilities of deep myometrial invasion in patients with tumor grades 1, 2, or 3 were 13%, 35%, or 54%, respectively. Posttest probabilities of deep myometrial invasion for grades 1, 2, or 3 increased to 60%, 84%, or 92%, respectively, for positive and decreased to 1%, 5%, or 10%, respectively, for negative MR imaging findings.

Conclusion: Use of contrast-enhanced MR imaging significantly affects the posttest probability of deep myometrial invasion in patients with all grades of endometrial cancer and could be used to select patients for specialist referral.

Citing Articles

Conservative treatment of endometrial cancer in women of reproductive age (Review).

Bourou M, Matsas A, Vrekoussis T, Mastorakos G, Valsamakis G, Panoskaltsis T Mol Clin Oncol. 2023; 19(1):55.

PMID: 37323245 PMC: 10265581. DOI: 10.3892/mco.2023.2651.


Machine Learning-Based Gray-Level Co-Occurrence Matrix (GLCM) Models for Predicting the Depth of Myometrial Invasion in Patients with Stage I Endometrial Cancer.

Qin L, Lai L, Wang H, Zhang Y, Qian X, He D Cancer Manag Res. 2022; 14:2143-2154.

PMID: 35795827 PMC: 9252192. DOI: 10.2147/CMAR.S370477.


Fertility issue in early stage endometrial cancer patients.

Topcu H, Kaya C, Oral E Transl Cancer Res. 2022; 9(12):7797-7808.

PMID: 35117382 PMC: 8797551. DOI: 10.21037/tcr-20-2232.


Endometrial cancer from early to advanced-stage disease: an update for radiologists.

Luna C, Balcacer P, Castillo P, Huang M, Alessandrino F Abdom Radiol (NY). 2021; 46(11):5325-5336.

PMID: 34297164 DOI: 10.1007/s00261-021-03220-7.


Diagnostic Value of FDG PET/MRI in Females With Pelvic Malignancy-A Systematic Review of the Literature.

Nguyen N, Beriwal S, Moon C, DArdenne N, Mountz J, Furlan A Front Oncol. 2020; 10:519440.

PMID: 33123460 PMC: 7571667. DOI: 10.3389/fonc.2020.519440.